Navelbine Capsule Use In Pregnancy & Lactation

Pregnancy: Navelbine is suspected to cause serious birth effects when administered during pregnancy. Navelbine is contra-indicated in pregnancy. In case of a vital indication for treatment with Navelbine during pregnancy a medical consultation concerning the risk of harmful effects for the child should be conducted. If pregnancy occurs during treatment genetic counselling should be offered.
Women of child-bearing potential: Women of child-bearing potential must use effective contraception during treatment and up to 3 months after treatment.
Lactation: It is unknown whether vinorelbine is excreted in human breast milk. The excretion of vinorelbine in milk has not been studied in animal studies. A risk to the suckling child cannot be excluded therefore breast feeding must be discontinued before starting treatment with Navelbine.
Fertility: Men being treated with Navelbine are advised not to father a child during and minimally up to 3 months after treatment.
Prior to treatment advice should be sought for conserving sperm due to the chance of irreversible infertility as a consequence of treatment with vinorelbine.